Novogene Co., Ltd. (688315.SS)
CNY 14.06
(0.21%)
CNY 14.06
(0.21%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2 Billion CNY | 3.98% |
| 2022 | 1.92 Billion CNY | 3.17% |
| 2021 | 1.86 Billion CNY | 25.26% |
| 2020 | 1.49 Billion CNY | -2.92% |
| 2019 | 1.53 Billion CNY | 45.68% |
| 2018 | 1.05 Billion CNY | 42.5% |
| 2017 | 739.34 Million CNY | 61.26% |
| 2016 | 458.47 Million CNY | 47.98% |
| 2015 | 309.82 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 467.39 Million CNY | -18.46% |
| 2024 Q2 | 527.24 Million CNY | 12.8% |
| 2024 Q3 | 522.52 Million CNY | -0.89% |
| 2023 Q2 | 489.31 Million CNY | 11.05% |
| 2023 Q3 | 499.15 Million CNY | 2.01% |
| 2023 Q4 | 573.19 Million CNY | 14.83% |
| 2023 Q1 | 440.6 Million CNY | -21.43% |
| 2023 FY | 2 Billion CNY | 3.98% |
| 2022 Q1 | 386.62 Million CNY | -34.51% |
| 2022 Q4 | 560.81 Million CNY | 8.87% |
| 2022 Q3 | 515.1 Million CNY | 11.23% |
| 2022 Q2 | 463.09 Million CNY | 19.78% |
| 2022 FY | 1.92 Billion CNY | 3.17% |
| 2021 Q3 | 474.26 Million CNY | 8.67% |
| 2021 FY | 1.86 Billion CNY | 25.26% |
| 2021 Q4 | 590.4 Million CNY | 24.49% |
| 2021 Q2 | 436.41 Million CNY | 19.46% |
| 2021 Q1 | 365.31 Million CNY | -31.81% |
| 2020 Q3 | 369.14 Million CNY | 1.83% |
| 2020 Q2 | 362.5 Million CNY | 62.82% |
| 2020 FY | 1.49 Billion CNY | -2.92% |
| 2020 Q1 | 222.63 Million CNY | -62.25% |
| 2020 Q4 | 535.74 Million CNY | 45.13% |
| 2019 Q4 | 589.75 Million CNY | 57.27% |
| 2019 Q3 | 375 Million CNY | 4.74% |
| 2019 Q2 | 358.02 Million CNY | 68.84% |
| 2019 FY | 1.53 Billion CNY | 45.68% |
| 2019 Q1 | 212.05 Million CNY | -34.69% |
| 2018 Q1 | 202.08 Million CNY | 0.0% |
| 2018 Q4 | 324.69 Million CNY | 0.0% |
| 2018 FY | 1.05 Billion CNY | 42.5% |
| 2018 Q3 | 324.69 Million CNY | 60.67% |
| 2018 Q2 | 202.08 Million CNY | 0.0% |
| 2017 FY | 739.34 Million CNY | 61.26% |
| 2016 FY | 458.47 Million CNY | 47.98% |
| 2015 FY | 309.82 Million CNY | 0.0% |